Test concordance and diagnostic accuracy of three serological assays for detection of anti-SARS-CoV-2 antibody: result from a population-based sero-epidemiological study in Delhi
Authors:
Open Access
- 7 December 2022
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 22 (1) , 1-6
Abstract
Background: Several methodological tests are available to detect SARS-CoV-2 antibody. Tests are mostly used in the aid of diagnosis or for serological assessment. No tests are fully confirmatory and have variable level of diagnostic ability. We aimed at assessing agreement with three serological tests: quantitative anti receptor binding domain ELISA (Q-RBD), qualitative ELISA (WANTAI SARS-CoV-2 Ab) and qualitative chemiluminescence assay (CLIA). Methods: This study was a part of a large population based sero-epidemiological cohort study. Participants aged 1 year or older were included from 25 randomly selected clusters each in Delhi urban (urban resettlement colony of South Delhi district) and Delhi rural (villages in Faridabad district, Haryana). Three type of tests were applied to all the baseline blood samples. Result of the three tests were evaluated by estimating the total agreement and kappa value. Results: Total 3491 blood samples collected from March to September, 2021, out of which 1700 (48.7%) from urban and 1791 (51.3%) from rural. Overall 44.1% of participants were male. The proportion of sero-positivity were 78.1%, 75.2% and 31.8% by Wantai, QRBD and CLIA tests respectively. The total agreement between Wantai and QRBD was 94.5%, 53.1% between Wantai and CLIA, and 56.8% between QRBD and CLIA. The kappa value between these three tests were 0.84 (95% CI 0.80–0.87), 0.22 (95% CI 0.19–0.24) and 0.26 (95% CI 0.23–0.28). Conclusions: There was strong concordance between Wantai and QRBD test. Agreement between CLIA with other two tests was low. Wantai and QRBD tests measuring the antibody to same S protein can be used with high agreement based on the relevant scenario.Keywords
All Related Versions
This publication has 10 references indexed in Scilit:
- How to interpret and use COVID-19 serology and immunology testsClinical Microbiology and Infection, 2021
- SARS‐CoV‐2 antibodies: IgA correlates with severity of disease in early COVID‐19 infectionJournal of Medical Virology, 2021
- Serological Tests in the Detection of SARS-CoV-2 AntibodiesDiagnostics, 2021
- The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNANature Communications, 2021
- COVID-19 Antibody Tests: A Valuable Public Health Tool with Limited Relevance to IndividualsTrends in Microbiology, 2021
- Serological follow-up of SARS-CoV-2 asymptomatic subjectsScientific Reports, 2020
- Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19Acta Pharmacologica Sinica, 2020
- Serum IgA, IgM, and IgG responses in COVID-19Cellular & Molecular Immunology, 2020
- Characteristics and assessment of the usefulness of serological tests in the diagnostic of infections caused by coronavirus SARS-CoV-2 on the basis of available manufacturer’s data and literature reviewPrzeglad Epidemiologiczny, 2020
- Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2Journal of Clinical Microbiology, 2020